{"DataElement":{"publicId":"8081490","version":"1","preferredName":"Person Prior Platinum Compound Chemotherapy Exposure Eligibility Status","preferredDefinition":"The status of whether a subject is suitable for enrollment in a study based on prior exposure to platinum compound chemotherapy.","longName":"PLT_CHEM_EXPO_ELIG_STAT","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"8081487","version":"1","preferredName":"Person Prior Platinum Compound Chemotherapy Exposure","preferredDefinition":"A human being._Earlier in time or order._A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis._The use of synthetic or naturally-occurring chemicals for the treatment of diseases._The act of subjecting someone or something to an influencing experience.","longName":"2236731v1.0:8081485v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"8081485","version":"1","preferredName":"Prior Platinum Compound Chemotherapy Exposure","preferredDefinition":"Earlier in time or order.:A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.:The use of synthetic or naturally-occurring chemicals for the treatment of diseases.:The act of subjecting someone or something to an influencing experience.","longName":"C25629:C1450:C15632:C17941","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platinum Compound","conceptCode":"C1450","definition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Exposure","conceptCode":"C17941","definition":"The act of subjecting someone or something to an influencing experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F2E087-72E2-7014-E053-4EBD850AE06B","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F2E087-72F3-7014-E053-4EBD850AE06B","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"SOKKERL","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8081488","version":"1","preferredName":"Eligibility Determination Status","preferredDefinition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures._A condition or state at a particular time.","longName":"8081488v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"0","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Chemotherapy Ineligible","valueDescription":"Chemotherapy Ineligibility","ValueMeaning":{"publicId":"8081489","version":"1","preferredName":"Chemotherapy Ineligibility","longName":"8081489","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: The state or quality of being disqualified by law, rule, or provision.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F33E69-CB4B-73AB-E053-4EBD850AAB73","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9F33E69-CB66-73AB-E053-4EBD850AAB73","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","deletedIndicator":"No"},{"value":"Platinum Ineligible","valueDescription":"Platinum Compound Ineligibility","ValueMeaning":{"publicId":"8081492","version":"1","preferredName":"Platinum Compound Ineligibility","longName":"8081492","preferredDefinition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.: The state or quality of being disqualified by law, rule, or provision.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platinum Compound","conceptCode":"C1450","definition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F2E6B3-9C2C-1ADE-E053-4EBD850A4724","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9F2E6B3-9C47-1ADE-E053-4EBD850A4724","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8081491","version":"1","preferredName":"Eligibility Determination Status","preferredDefinition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.:A condition or state at a particular time.","longName":"C25171:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F4B39E-8F14-68DF-E053-4EBD850ADEF7","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F33E69-CB30-73AB-E053-4EBD850AAB73","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"SOKKERL","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Prior Platinum Exposure","type":"Preferred Question Text","description":"Prior Platinum Exposure","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F194E8-6E2E-1AE0-E053-4EBD850AFEB9","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-03-11","modifiedBy":"SOKKERL","dateModified":"2022-03-11","changeDescription":"3/11/22","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}